-
European Hematology Association (EHA) 2024 has been an incredible journey
European Hematology Association (EHA) 2024 has been an incredible journey! Thank you to all the amazing professionals who made it unforgettable. hashtag#EHA2024 hashtag#Hematology hashtag#ConferenceHighlights hashtag#Research
-
European Hematology Association (EHA) 2024 Wrap-Up
European Hematology Association (EHA) 2024 Wrap-Up: A Confluence of Innovation and Collaboration The European Hematology Association (EHA) 2024 has concluded, leaving a trail of impactful insights and advancements in the field of hematology
-
Research Progress丨Analysis of Platinum Intolerance and Treatment Outcomes in First-Line Treatment of Advanced Urothelial Carcinoma Patients
Advanced urothelial carcinoma (UC) patients have a poor prognosis with a low 5-year survival rate. Since the 1980s, platinum-based chemotherapy has been the standard first-line therapy for locally advanced or metastatic UC (la/mUC), but the benefits are limited. The real-world tolerance and treatment outcomes of platinum therapy remain unclear. This year’s study analyzed data from…
-
Insightful Analysis and Future Blueprint: Academician Binghe Xu Highlights COMB, Outlining the Development of Innovative Breast Cancer Drugs in China
From August 2-4, 2024, the Seventh Tumor Precision Diagnosis and Treatment Conference and the Tenth Breast Cancer Individualized Treatment Conference (COMB), hosted by the China Cancer Foundation and the Beijing Breast Disease Prevention and Treatment Society, were grandly held in Beijing. The conference brought together the latest advancements in individualized precision treatment of breast cancer…
-
Celebrating World Breastfeeding Week!
Celebrating World Breastfeeding Week! From August 1st to 7th, we honor and support the beautiful journey of breastfeeding. Let’s join hands to promote the importance of breastfeeding for both mothers and babies. It’s more than just nourishment—it’s about bonding, health, and giving our little ones the best start in life
-
Dr. Chao Sun: Prospects for the Application of Bicyclol – Mechanisms, Therapeutic Significance, and Challenges
Bicyclol, derived from Schisandra chinensis, has been widely used in the treatment of various liver diseases since its approval by China’s National Medical Products Administration as a hepatoprotective drug. Viral…
-
Dr. Xuefeng Luo: In-Depth Analysis of TIPS in the Treatment of Budd-Chiari Syndrome
Overview of the Study BCS is a rare vascular disorder of the liver, characterized by obstruction of hepatic venous outflow, leading to portal hypertension and hepatic congestion. This potentially life-threatening…
Connecting Medical Expertise through Media
